Back to top
more

PerkinElmer, Inc. (PKI)

(Delayed Data from NYSE)

$96.59 USD

96.59
692,880

+1.71 (1.80%)

Updated May 3, 2019 04:03 PM ET

After-Market: $96.59 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

Here's Why You Should Retain AmerisourceBergen Stock Now

AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment and new product launches. However, stiff competition remains a woe.

Cerner (CERN) Inks Deal With Finland Regional Leadership

Cerner (CERN) collaborates with Finland regional leadership to help bring integrated health and care.

Varian Expands Access to Advanced Cancer Treatment With Ethos

Varian's (VAR) Ethos Therapy used by Goshen Center for Cancer Care marks the expansion access to personalized cancer care.

The Zacks Analyst Blog Highlights: Mettler-Toledo, PerkinElmer, Waters and Bruker

The Zacks Analyst Blog Highlights: Mettler-Toledo, PerkinElmer, Waters and Bruker

HealthEquity (HQY) Q2 Earnings and Revenues Beat Estimates

HealthEquity (HQY) witnessed strong growth in Service, Custodial and Interchange segments in Q2.

PRA Health (PRAH) Inks Deal With Leukemia & Lymphoma Society

PRA Health (PRAH) partners with LLS to bring new treatments for children with relapsed acute leukemia.

Here's Why You Should Hold on to Nevro (NVRO) Stock Now

Nevro (NVRO) continues to gain traction from Senza, its flagship platform, and R&D capabilities. However, stiff competition remains a woe.

Varian's Halcyon System to Bring Improved Care to Singapore

Varian (VAR) strengthens its partnership Proton Therapy Pte as it brings improved care to Singapore through Halcyon system.

Aniruddha Ganguly headshot

4 Stocks to Watch on Rising Demand for Scientific Instruments

The Zacks Instruments - Scientific industry is gaining from strong life science, pharmaceutical and academic end-market demand. Industry participants MTD, PKI, WAT and BRKR are set to gain from rising healthcare spending and exposure to developing economies like China and India.

NextGen Healthcare Introduces New Behavioral Health Suite

NextGen Healthcare's (NXGN) new behavioral health suite aims to provide whole person care with support services for healthcare providers and clinicians.

Cooper Companies (COO) Q3 Earnings & Revenues Top Estimates

Cooper Companies' (COO) fiscal third-quarter earnings reflect dismal segmental performance. However, it exceeded expectation as it witnessed faster-than-anticipated recovery.

Aurora Cannabis (ACB) to Post Q4 Earnings: What's in Store?

Aurora Cannabis' (ACB) fiscal fourth-quarter results likely to reflect solid prospects in the Canadian market.

Patterson Companies (PDCO) Q1 Earnings Top Estimates, Up Y/Y

Despite weak performance across Patterson Companies' (PDCO) Dental and Animal Health segments in the fiscal first quarter results, it benefited from aggressive cost savings measures.

Is PerkinElmer (PKI) Outperforming Other Computer and Technology Stocks This Year?

Is (PKI) Outperforming Other Computer and Technology Stocks This Year?

What's in Store for Patterson Companies' (PDCO) Q1 Earnings?

Patterson Companies' (PDCO) fiscal first-quarter results are likely to reflect sluggishness at Dental segment.

Here's Why You Should Invest in LHC Group (LHCG) Stock Now

LHC Group (LHCG) continues to gain traction from its broad range of services, and strategic acquisitions and joint ventures.

Cooper Companies (COO) to Post Q3 Earnings: What's in Store?

Cooper Companies' (COO) fiscal third-quarter performance is likely to reflect weak performance by CVI and CSI.

Urmimala Biswas headshot

Price War in Coronavirus Test Space to Intensify Thanks to Abbott

Most rapid antigen tests in the United States require an additional system, which is making the procedures more costly and complex.

Veeva Systems (VEEV) Q2 Earnings and Revenues Beat Estimates

Veeva Systems' (VEEV) core Subscription business segment performs impressively in Q2.

PerkinElmer (PKI) Down 0.2% Since Last Earnings Report: Can It Rebound?

PerkinElmer (PKI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Is PerkinElmer (PKI) a Great Growth Stock?

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider PerkinElmer (PKI).

AMN Healthcare's Advanced Mobile App to Aid Travel Clinicians

AMN Healthcare's (AMN) new version of AMN Passport will benefit travel clinicians.

Allscripts Enhances Healthcare Innovation With Patent Program

Allscripts (MDRX) continues to advance healthcare innovation by earning five new application patents.

Here's Why You Should Hold on to DENTSPLY (XRAY) Stock Now

DENTSPLY (XRAY) continues to gain traction from its solid focus on R&D leading to product innovation, which continues to be a key catalyst.

Here's Why You Should Invest in Fresenius Medical Stock Now

Fresenius Medical (FMS) continues to gain traction from its broad range of dialysis products and services.